Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online July 15, 2008
Diabetes 57:2843-2850, 2008
DOI: 10.2337/db08-0073
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db08-0073v1
57/10/2843    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Trégouet, D.-A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trégouet, D.-A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes

David-Alexandre Trégouet1, Per-Henrik Groop2,3, Steven McGinn4, Carol Forsblom2,3, Samy Hadjadj5,6, Michel Marre7,8, Hans-Henrik Parving9, Lise Tarnow10, Ralph Telgmann11, Tiphaine Godefroy1, Viviane Nicaud1, Rachel Rousseau1, Maikki Parkkonen3, Anna Hoverfält3, Ivo Gut4, Simon Heath4, Fumihiko Matsuda4, Roger Cox12, Gbenga Kazeem13, Martin Farrall13, Dominique Gauguier13, Stefan-Martin Brand-Herrmann11, François Cambien1, Mark Lathrop4, Nathalie Vionnet1 for the EURAGEDIC Consortium

1 INSERM, Paris, France, and Pierre and Marie Curie-Paris VI University, Paris, France
2 Helsinki University Central Hospital, Department of Medicine, Division of Nephrology, Helsinki, Finland
3 Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum, Helsinki, Finland
4 CEA/Institute of Genomics-National Genotyping Center, Evry, France
5 CHU Poitiers, Department of Diabetology, Poitiers, France
6 INSERM U927, CHU Poitiers, Poitiers, France
7 Assistance Publique des Hôpitaux de Paris, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris, France
8 Université Paris, INSERM U695, Paris, France
9 University Hospital of Copenhagen, Rigshospitalet, Department of Medical Endocrinology, Copenhagen, Denmark
10 Steno Diabetes Center, Copenhagen, Denmark
11 Leibniz Institute for Arteriosclerosis Research, Department of Molecular Genetics of Cardiovascular Disease, University of Muenster, Muenster, Germany
12 Mammalian Research Council, Mammalian Genetics Unit, Harwell, U.K
13 Wellcome Trust Center for Human Genetics, University of Oxford, Oxford, U.K

Corresponding author: Nathalie Vionnet, vionnet{at}cng.fr

OBJECTIVE— Genetic and environmental factors modulate the susceptibility to diabetic nephropathy, as initiating and/or progression factors. The objective of the European Rational Approach for the Genetics of Diabetic Complications (EURAGEDIC) study is to identify nephropathy susceptibility genes. We report molecular genetic studies for 127 candidate genes for nephropathy.

RESEARCH DESIGN AND METHODS— Polymorphisms were identified through sequencing of promoter, exon, and flanking intron gene regions and a database search. A total of 344 nonredundant SNPs and nonsynonymous variants were tested for association with diabetic nephropathy (persistent albuminuria ≥300 mg/24 h) in a large type 1 diabetes case/control (1,176/1,323) study from three European populations.

RESULTS— Only one SNP, rs2281999, located in the UNC13B gene, was significantly associated with nephropathy after correction for multiple testing. Analyses of 21 additional markers fully characterizing the haplotypic variability of the UNC13B gene showed consistent association of SNP rs13293564 (G/T) located in intron 1 of the gene with nephropathy in the three populations. The odds ratio (OR) for nephropathy associated with the TT genotype was 1.68 (95% CI 1.29–2.19) (P = 1.0 x 10–4). This association was replicated in an independent population of 412 case subjects and 614 control subjects (combined OR of 1.63 [95% CI 1.30–2.05], P = 2.3 x 10–5).

CONCLUSIONS— We identified a polymorphism in the UNC13B gene associated with nephropathy. UNC13B mediates apopotosis in glomerular cells in the presence of hyperglycemia, an event occurring early in the development of nephropathy. We propose that this polymorphism could be a marker for the initiation of nephropathy. However, further studies are needed to clarify the role of UNC13B in nephropathy.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.